Biomarkers in spinal muscular atrophy
Spinal muscular atrophy is a hereditary disorder leading to severe neuromuscular impairment. With the introduction of disease-modifying therapies in recent years, the role of biomarkers has expanded from aiding diagnosis to monitoring treatment responses, prognostic assessment, and the development o...
Saved in:
| Main Authors: | Liping Yan, Jinping Zhang, Jian Zheng, Hua Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1636992/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of genetic testing and prenatal diagnosis of spinal muscular atrophy in Jordan
by: Mohammad Shboul, et al.
Published: (2025-12-01) -
Insights into diagnostic difficulties in spinal muscular atrophy: a Case Report series
by: Kakha Bregvadze, et al.
Published: (2024-12-01) -
MicroRNAs as Biomarkers in Spinal Muscular Atrophy
by: Maruša Barbo, et al.
Published: (2024-10-01) -
The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
by: Marianna Maretina, et al.
Published: (2024-10-01) -
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
by: Jonathan J. Cherry, et al.
Published: (2013-06-01)